Targeted Therapies for Myeloma and Metastatic Bone Cancers

Abstract

Developed two procedures for preparing nanoparticles and demonstrated their ability to repeatedly produce nanoparticles with narrow distribution in the target particle size range of 70-200nm and smaller, if necessary. Synthesized and fully characterized PLA-b-PEG-Maleimide block copolymers to facilitate the attachment of bone-targeting ligands to polymer nanoparticles via thiol coupling. Improved lyostability of polymer nanoparticles, with and without PEG modification. Developed methods to radiolabel polymer nanoparticles, the first time, to our knowledge, this has been done. Encapsulated two proteasome inhibitors, MG-132 and PS-1, and determined their in vitro release profiles. Developed proteasome activity assay to determine activity of encapsulated drug. Developing in vitro assay to determine affinity of bone-targeting nanoparticles to hydroxyapatite substrates.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Feb 01, 2007
Accession Number
ADA467829

Entities

People

  • Neal Vail

Organizations

  • Southwest Research Institute

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Block Copolymers
  • Bone And Bones
  • Chemistry
  • Copolymers
  • Department Of Defense
  • Hydrophilic Properties
  • Hydrophobic Properties
  • Imides
  • Inhibitors
  • Materials
  • Mixtures
  • Molecules
  • Nanoparticles
  • Particle Size
  • Particles
  • Polymers
  • Quantum Dots

Fields of Study

  • Chemistry

Readers

  • Nanocomposite Materials Science
  • Oncology (Cancer Research).

Technology Areas

  • Biotechnology
  • Biotechnology - Cancer Biotech
  • Microelectronics